These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 16105135

  • 21. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis.
    Hyogo H, Yamagishi S, Iwamoto K, Arihiro K, Takeuchi M, Sato T, Ochi H, Nonaka M, Nabeshima Y, Inoue M, Ishitobi T, Chayama K, Tazuma S.
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1112-9. PubMed ID: 17559366
    [Abstract] [Full Text] [Related]

  • 22. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
    Bahcecioglu IH, Yalniz M, Ataseven H, Ilhan N, Ozercan IH, Seckin D, Sahin K.
    Hepatogastroenterology; 2005 Jul; 52(65):1549-53. PubMed ID: 16201116
    [Abstract] [Full Text] [Related]

  • 23. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis.
    Sajjad A, Mottershead M, Syn WK, Jones R, Smith S, Nwokolo CU.
    Aliment Pharmacol Ther; 2005 Aug 15; 22(4):291-9. PubMed ID: 16097995
    [Abstract] [Full Text] [Related]

  • 24. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ.
    Scand J Gastroenterol; 2008 Aug 15; 43(9):1128-36. PubMed ID: 18609175
    [Abstract] [Full Text] [Related]

  • 25. Pathogenesis of non-alcoholic steatohepatitis: human data.
    Edmison J, McCullough AJ.
    Clin Liver Dis; 2007 Feb 15; 11(1):75-104, ix. PubMed ID: 17544973
    [Abstract] [Full Text] [Related]

  • 26. [Fatty liver assessed by histologic examination in patients with hyperlipoproteinemia].
    Tacikowski T, Milewski B, Dzieniszewski J, Walewska-Zielecka B.
    Wiad Lek; 1994 Oct 15; 47(19-20):731-7. PubMed ID: 7483618
    [Abstract] [Full Text] [Related]

  • 27. High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy.
    Stejskal D, Růzicka V, Fanfrdlová G, Kolár V, Bartek J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun 15; 149(1):93-9. PubMed ID: 16170395
    [Abstract] [Full Text] [Related]

  • 28. Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease.
    Senturk O, Kocaman O, Hulagu S, Sahin T, Aygun C, Konduk T, Celebi A.
    Intern Med J; 2008 Mar 15; 38(3):183-9. PubMed ID: 17725609
    [Abstract] [Full Text] [Related]

  • 29. [Obesity and non-alcoholic steatohepatitis].
    Méndez-Sánchez N, Chávez-Tapia NC, Uribe M.
    Gac Med Mex; 2004 Mar 15; 140 Suppl 2():S67-72. PubMed ID: 15641474
    [Abstract] [Full Text] [Related]

  • 30. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM, Petrovic LM, Talal AH, Murray MP, Gulick RM, Glesby MJ.
    J Infect Dis; 2005 Dec 01; 192(11):1943-9. PubMed ID: 16267765
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
    Yalniz M, Bahcecioglu IH, Kuzu N, Poyrazoglu OK, Bulmus O, Celebi S, Ustundag B, Ozercan IH, Sahin K.
    J Gastroenterol Hepatol; 2007 Nov 01; 22(11):2009-14. PubMed ID: 17914984
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S, Younossi ZM.
    Minerva Gastroenterol Dietol; 2006 Jun 01; 52(2):135-43. PubMed ID: 16557185
    [Abstract] [Full Text] [Related]

  • 36. Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease.
    Polyzos SA, Kountouras J, Patsiaoura K, Katsiki E, Zafeiriadou E, Zavos C, Deretzi G, Tsiaousi E, Slavakis A.
    Int J Food Sci Nutr; 2012 Sep 01; 63(6):659-66. PubMed ID: 22229957
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S, Muratore C, Craxì A.
    Dig Liver Dis; 2009 Sep 01; 41(9):615-25. PubMed ID: 19223251
    [Abstract] [Full Text] [Related]

  • 39. Dietary habits and nutrient intake in non-alcoholic steatohepatitis.
    Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y, Kawamura M, Ebihara K, Onji M.
    Nutrition; 2007 Jan 01; 23(1):46-52. PubMed ID: 17140767
    [Abstract] [Full Text] [Related]

  • 40. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S, López-Alvarenga JC, Uribe-Uribe NO, Herrera-Hernández M, González-Barranco J.
    Rev Invest Clin; 2005 Jan 01; 57(4):505-12. PubMed ID: 16315634
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.